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Abstract
Background: As patient satisfaction scores become increasingly relevant in today’s health care market, we sought
to evaluate satisfaction of the unique subset of patients enrolling in clinical trials in a research facility embedded
within a community hospital system.
Methods: We developed and deployed a patient satisfaction survey tailored to clinical trial patients who consented
to and/or completed a clinical trial in our research institute in the prior year. The survey was distributed to 222
patients. Likert scale responses were analyzed using top box and percentile rank procedures. Correlation analysis
was used to evaluate associations between the clinical trial experience and intent to return to our system for
routine care.
Results: Ninety surveys were returned in the 6 months following the mailing for a 41 % response rate; the bulk of
these (N = 81) were returned within 6 weeks of the mailing. The questions with the highest ranking responses were
related to interactions with staff (84th percentile or higher). Fifty-one point one percent of patients (64th percentile)
strongly agreed that they would seek future care in our system. Patient intent to return to the provider seen during
the clinical trial was most highly correlated with intent to seek future care within our system (r = 0.54, p < 0.0001).
Reasons cited for clinical trial enrollment were generally altruistic.
Conclusions: Querying this special patient population is feasible and yields valuable insight into their experience
with healthcare system-based clinical trials and the relationship between clinical trial participation and perception
of the healthcare system as a desirable resource for routine medical care. We argue that this work is invaluable to
the research community and submit a call to action to our peers to begin systematic evaluation of clinical trial
patient satisfaction.
Background
Patient satisfaction is an increasingly important measure
in health care delivery. In the United States, commercial
surveys, such as the Hospital Consumer Assessment of
Healthcare Providers and Systems (HCAHPS) survey [1],
are now conducted on a national scale and used rou-
tinely to satisfy internal and external demands for this
information. In October 2012, the Centers for Medicare
and Medicaid Services began to tie hospital reimburse-
ments to standardized HCAHPS scores [2]. As the
health care market becomes increasingly competitive
and consumer-driven, patient satisfaction scores have
the potential to influence consumer decisions about the
utilization of health care resources, and studies have
demonstrated positive associations between overall patient
satisfaction and clinical outcomes [3, 4]. Standardization
of patient satisfaction scores empowers health care con-
sumers and leaders alike to evaluate and compare a con-
sistent measure of the patient experience between
institutions. Finally, it has been shown that patients who
are “merely satisfied” with their health care experience are
likely to seek future care elsewhere [5], an important find-
ing for competing health care systems that are at risk of
losing customers in response to low satisfaction.
Health care organizations with embedded research pro-
grams likely experience substantial crossover between re-
search patients and patients seeking routine care; research
may attract new patients to the system and the system can
engage existing patients in research. Overall patient satis-
faction has been shown to correlate most highly with
communication with nurses [6], and research patients in
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an embedded research division interact with an additional
team of study staff, often nurses and/or certified clinical
research coordinators/assistants, who represent the larger
organization. While the satisfaction of patients seeking
routine care is now formally measured within most large
health care systems [7], and the motivation of research
patients for participating in clinical trials has been well-
described [8–12], there is a dearth of information regar-
ding the satisfaction of research patients with their clinical
trial experience or the relationship between research pa-
tient satisfaction and use of the host institution for routine
medical care. Notably, the 3rd International Clinical Trials
Methodology Conference held in Glasgow in late 2015 in-
cluded two posters addressing the patient experience of
clinical trial participants. One systematic literature review
(1995–2014) identified only five research patient expe-
rience measures [13], while a second reported results of a
survey conducted with 44 clinical trial participants [14].
This suggests that while an international discussion about
patient satisfaction is underway, it remains nascent.
Several unique aspects of the research patient expe-
rience, such as informed consent and patient incentives
for study enrollment, are not part of routine care and
thus cannot be evaluated by standardized patient expe-
rience surveys designed to assess the provision of nonre-
search health care services. Two substantial gaps are
created by the absence of a standardized and widely used
survey explicitly designed to assess the unique patient
experience of clinical trial participants: first, the research
community operates in the absence of benchmarks by
which to identify programmatic strengths/weaknesses
and upon which to base improvements; second, the
patient voice is lost.
We sought to develop an independent questionnaire
that would (1) evaluate the satisfaction of patients par-
ticipating in clinical trials within our research institute,
(2) establish internal, measureable benchmarks to allow
ongoing evaluation of service to our clinical trial partici-
pants, and (3) identify existing associations between pa-
tient engagement in clinical trials and use of our health
care system for nonresearch medical care. Perhaps most
importantly, however, this work is a call to action for the
broader research community: it is time that we engage
in a national/international conversation about the im-
portance of measuring the experience of clinical trial pa-
tients and begin to develop a method and framework for
evaluating clinical trial patient satisfaction, creating
benchmarks, hearing the clinical trial patient voice, and
making local improvements in response.
Methods
Setting
The MultiCare Institute for Research and Innovation
(MIRI) is the largest medical research organization in
the South Puget Sound region of Washington State. Em-
bedded within the MultiCare community Hospital System
(MHS), MIRI conducts research into more than ten thera-
peutic areas at 19 clinical sites. Federally funded oncology
clinical trials had been conducted at MultiCare for nearly
three decades prior to the launch of MIRI in its current
form, and that work continues today with MIRI serving as
primary recipient for the Northwest National Cancer
Institute Community Oncology Research Program.
With MIRI’s establishment came a formal expansion of
research endeavors into additional therapeutic areas and
the development of an investigator-initiated research pro-
gram. In 2014, MIRI had over 800 patients active in 87
industry-sponsored or 65 federally funded clinical trials.
Fifty-three MHS employed physicians acted as principal
or sub-investigators on these trials. Although MIRI has its
own staff of over 20 clinical research coordinators/assis-
tants, patients are seen in MultiCare facilities and our staff
members are all MultiCare employees. Further blurring
the distinction between MultiCare and MIRI, many trials
include visits during which both standard-of-care and
research specific procedures occur. Research patients are
unlikely to make a distinction between the research and
routine care aspects of their visits, thus strengthening the
association between the clinical trial patient experience
and patient perception of the MultiCare system as a
resource for nonresearch-related medical care.
Survey development
To create a patient satisfaction survey tailored to clinical
trial patients we reviewed the literature [8, 15–18], the
standardized outpatient survey distributed by a third-party
vendor with which our organization contracts, surveys de-
veloped by two internal departments (Home Health and
Hospice and Sleep Disorders Center), and additional pa-
tient satisfaction surveys that were freely available online.
Several common areas of inquiry emerged from these re-
views including satisfaction with scheduling, facility, staff/
providers, overall satisfaction, and likelihood to return for
further care or to recommend the facility to family/friends.
We also conducted two brainstorming sessions, first as
the MIRI leadership team and subsequently with our insti-
tution’s Research Oversight Committee, to identify areas
of inquiry specific to the clinical trial patient experience.
As the survey was to be used as part of our quality
improvement process, we did not apply for Institutional
Review Board approval prior to mailing it to patients.
However, the MultiCare Institutional Review Board granted
exemption for use of the results from this anonymous sur-
vey for manuscript preparation in April 2015 under proto-
col number EX-95, and return of a completed survey was
considered implied consent.
Development of this survey held the dual purpose of
first evaluating the feasibility of distributing and analyzing
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results from a clinical trial participant patient satisfaction
survey, and subsequently establishing an internal baseline
for use in ongoing assessment of the experience of this
unique patient population until a national benchmark
becomes available. The author (BMP) developed an initial
draft of the survey which was then refined with input from
the four-member MIRI leadership team (PJA, AR, RP, and
SR) responsible for oversight of all research operations
and staff. The penultimate version of the survey was then
vetted by MultiCare’s Research Oversight Committee
which is comprised of 18 physician leaders and high-level
administrators and executives within the MultiCare sys-
tem. The leadership team, in concert with the Research
Oversight Committee, identified patients who had (1) con-
sented to a trial in the past year or (2) completed a trial in
the past year to which they had consented more than 1
year prior as target survey recipients. The goal of this
stratification was to be able to capture a range of recent
patient experiences while simultaneously identifying dis-
parities in the perspectives of patients who were at the
beginning or end of their research participation. Due to
resource limitations, no follow-up phone calls or emails
were made after mailing the survey.
The final instrument (see Additional file 1) included
seven questions related to the study (how they learned
of the study, medical condition, number of visits, etc.),
27 questions on a 5-point Likert scale (Strongly Agree,
Agree, Neutral, Disagree, Strongly Disagree), two rank-
ing questions, three free-text response options, and four
demographic questions (sex, age, ethnicity, and zip code)
for a total of 45 questions on three pages. The instru-
ment also included a preface statement requesting feed-
back, instructing the patient to return the questionnaire
in the enclosed postage-paid envelope, and informing
the patient that all responses would be anonymous and
kept confidential. As this was the initial foray into as-
sessment of the clinical trial patient experience, the deci-
sion was made to allow the survey to be longer than
others that we reviewed and to include several poten-
tially related questions. We proceeded with the expect-
ation that we would reduce the length of the survey in
the following year after reflecting upon the survey ad-
ministration experience, analyzing results, and identify-
ing questions that most effectively captured the data of
interest.
Analyses
Likert scale questions were evaluated using both a “top
box” score (the percentage of respondents who selected
Strongly Agree for each question) and a Six Sigma per-
centile rank procedure [19]. The percentile rank pro-
cedure compares each question’s mean to a benchmark
value of 4 (Agree) [20], incorporating the variability of
the responses by normalizing the data and finding a
percentile rank based on the standard normal distribu-
tion. Correlation analysis was used to evaluate associa-
tions between intended future use of our health care
system for routine care and the 26 other Likert measures
of patient satisfaction. Pairwise correlations between all
Likert scale items were also reviewed to identify redun-
dant questions and unexpected associations. Free-text
responses were not formally analyzed, but were reviewed
from a quality improvement perspective as anecdotal
feedback. Surveys with missing data were excluded from
analyses at the question level only. Holm-Bonferroni ad-
justed p values were calculated to account for the bur-
den of multiple testing. All analyses were performed in
the R statistical computing environment [21].
Results
In June 2014 the survey was mailed to 226 patients
identified as having (1) consented to a study in the past
year (N = 125, 55 %) or (2) completed a trial in the past
year to which they had consented more than 1 year
prior (N = 101, 45 %). Three surveys were returned with
no forwarding address and one patient died prior to re-
ceiving the survey, so the survey was believed to have
been received by 222 patients (Nconsented = 122, Ncompleted =
100). Ninety surveys (41 %) were returned between June
and November 2014, 81 of which (90 %) were received
within 6 weeks of the mailing. Missing data were present in
six (6.6 %) surveys: four (4.4 %) were missing one data
point, one (1.1 %) was missing two data points, and one
(1.1 %) patient completed only the first page of the survey.
A significantly higher proportion of the patients in the con-
sented group returned the survey compared to the patients
who had completed a study (50 % versus 29 %, p = 0.002).
Forty-four respondents (48.8 %) were female, 63 (70.0 %)
were aged 55 or older and 73 (81.1 %) self-identified as
Caucasian. Fifty-two respondents (57.7 %) reported a home
zip code within 15 miles of MIRI’s main research facility
(Tables 1 and 2). Respondent distribution by therapeutic
area is presented in Table 3.
The highest positive responses were related to patient-
staff interactions, with a percentile rank of 90 or higher
for staff friendliness (96.8th percentile), respect for pa-
tients (94.9th percentile), time spent with patients (94.9th
percentile), explanation of role in the study (90.8th per-
centile), and answering questions fully (90.3th percentile;
Table 4). Facility cleanliness and environment were well-
rated (86.7th percentile and 81.3th percentile) but parking
and convenience of location less so (68.6th percentile and
61.7th percentile). Although the rankings for satisfaction
with care and the likelihood of returning to the provider
were at the 83rd percentile, overall questions related to
enrolling in future trials, enjoying visits, and believing that
medical care was enhanced by the study ranked below the
62nd percentile. Fifty-one point one percent of patients
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strongly agreed that they would seek future care in our
hospital system (64th percentile).
Six items were significantly correlated with participant
intention to seek future medical care at a MultiCare facil-
ity. All of these correlations were positive and moderate
(0.36–0.54, Table 5), and four relate to the relationship
with staff. Patient intent to return to the health care pro-
vider for routine care was most highly correlated with this
item (r = 0.54, p < 0.0001). Intent to encourage others to
participate in studies (r = 0.34, p = 0.0013) and enjoyment
of study visits (r = 0.33, p = 0.0016), although statistically
significant, had Pearson correlation values that are gen-
erally considered weak. Evaluation of all pairwise corre-
lations showed strong correlations between perception
of a pleasant environment and ease of visit scheduling
(r = 0.85), trust in research staff (r = 0.77), confidence in
skills/knowledge of staff (r = 0.72), and perception of rapid
and full response to concerns (r = 0.70, all p < 0.0001).
Sixty-seven respondents (74.4 %) cited contribution to
medical science and potentially helping others with similar
conditions as a primary motivation for volunteering for
their research study. An additional 61 respondents (67.8 %)
indicated that a primary motivation was the hope that their
own medical condition would be improved. Financial in-
centives were least cited (N = 16, 17.8 %) as a primary mo-
tivation for participation (Table 6).
Discussion
This preliminary evaluation of research patient satisfac-
tion demonstrates that querying this special patient
population is feasible and yields valuable insight. Our re-
sponse rate of 41 % is nearly 2.5 times that of the 17 %
response rate to our hospital system’s vendor-based out-
patient services survey. This may be reflective of a high
level of engagement of patients who participate in clin-
ical trials, or suggestive of a heightened willingness of
this population to share their perspective; regardless, this
response rate underscores the need for the clinical trial
patient voice to be heard by the research community.
Patients who had consented to a study in the past year
were more likely to reply to the survey than patients
who had completed a study in the past year. This could
be due to a feeling of the experience being more “fresh”
as study enrollment was concurrent to survey receipt.
Motivations of our research patients were similar to
those described in the literature [11, 12, 15, 16, 22], with
altruism acting as the primary motivating factor in the
decision to enroll on a trial. Our staff was highly rated
by participants and free-text responses reflected satisfac-
tion with the staff. However, in the absence of national
benchmarks and systematic polling of clinical trial pa-
tients immediately following a visit it is not possible to
execute a true assessment of the quality of patient-staff
interactions in our research institute, as these seemingly
“high” scores are not situated in a broader patient ex-
perience context and it is unknown if patients who had
a negative clinical trial experience were prone to re-
spond to this one-time mailing that may have occurred
up to a year after their visit.
The observed correlations between an intent to return
to our system for care and several variables were weak to
moderate (0.33–0.54) and the associations warrant further
explanation before basing process or organization changes
on them. Fifty-four percent of the patients who indicated
intent to return to MHS for routine care reported a zip
code within 15 miles of our main research facility, but
with system medical facilities throughout the South Puget
Sound region it is difficult to ascertain the extent to which
distance influenced this response. An unanticipated fin-
ding was the set of strong correlations between perception
of a pleasant environment and modifiable aspects of the
study, such as scheduling, trust/confidence in the staff,
and satisfactory response by staff to patient concerns.
Local directions for future work include revision of the
clinical trial patient survey to align with the vendor-
based outpatient survey used by our institution. We be-
lieve that this will enable us to locate our own patient
satisfaction profile within the broader context of patient
Table 1 Demographics and background
Survey recipients Survey respondents MHS patient population
N % N % %
Female 111 49.1 44 48.9 52.4
Aged ≥55 years 135 59.7 63 70.0 24.3
Caucasian 191 85.7 73 81.1 73.6
Consented 125 55.3 61 67.8 -
MHS MultiCare Health System
Table 2 Additional respondent characteristics
Number Percent
Residence zip code <15 miles from main MIRI facility 59 65.6
Received care at MHS prior to study enrollment 76 84.4
Doctor recommended the study during a visit 67 74.4
Made ≥4 visits for the study 62 68.9
MHS MultiCare Health System, MIRI MultiCare Institute for Research
and Innovation
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Table 3 Survey respondent therapeutic area of study
Survey recipients Survey respondents % responded within
therapeutic area
Therapeutic area N % N % %
Cardiovascular 40 17.7 18 20.0 45.0
Endocrinology 24 10.6 12 13.3 50.0
Internal medicine 3 1.3 2 2.2 66.7
Neurology 43 19.0 16 17.8 37.2
Oncology 26 11.5 10 11.1 38.5
Pediatrics 22 9.7 2 2.2 9.1
Pulmonology 62 27.4 25 27.8 40.3
Stroke 6 2.7 3 3.3 50.0
Not reported - - 2 2.2 -
Table 4 Survey questions and results
Question NA % strongly agree Percentile rank Mean SD Z score
Friendly staff 1 80.0 96.8 4.80 0.43 1.85
Respectful staff 1 75.6 94.9 4.75 0.46 1.64
Adequate time spent 1 72.2 94.9 4.73 0.45 1.64
Staff explained role 1 66.7 90.8 4.66 0.50 1.33
Staff answered questions 1 65.6 90.3 4.65 0.50 1.30
Staff explained procedures 1 64.4 88.2 4.63 0.53 1.19
Fully informed of risks/benefits 1 63.3 87.7 4.62 0.53 1.16
Staff protected privacy 1 65.6 87.3 4.63 0.55 1.14
Trusted staff 1 64.4 86.8 4.62 0.55 1.12
Clean facility 0 66.7 86.7 4.63 0.57 1.11
Staff were prepared 1 71.1 86.5 4.66 0.60 1.10
Reasonable wait time 0 61.1 86.3 4.59 0.54 1.09
Confident in staff skills/knowledge 1 63.3 86.2 4.61 0.56 1.09
Staff responded to concerns 1 65.6 84.4 4.62 0.61 1.01
Extremely satisfied with care 1 64.4 83.3 4.60 0.62 0.97
Would return to provider for care 1 66.7 83.0 4.62 0.65 0.95
Visit times were convenient 0 61.1 81.5 4.56 0.62 0.90
Environment was pleasant 0 63.3 81.3 4.57 0.64 0.89
Scheduling visits was easy 0 63.3 78.5 4.54 0.69 0.79
Received reminders for visits 4 57.8 71.7 4.45 0.79 0.57
Parking was easy 1 52.2 68.6 4.38 0.79 0.48
Will seek future care at MHS 1 51.1 64.5 4.33 0.88 0.37
Convenient location 1 45.6 61.7 4.25 0.83 0.30
Would do another study 1 52.2 61.3 4.27 0.94 0.29
Enjoyed visits 1 38.9 59.1 4.18 0.78 0.23
Will encourage others to do studies 1 35.6 52.1 4.04 0.84 0.05
Medical care enhanced by study 1 40.0 50.0 4.00 1.00 0.00
MHS MultiCare Health System
NA represents the number of respondents who did not answer the associated question
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satisfaction in our organization until national bench-
marking data become available through widespread
evaluation of the clinical trial patient experience. It has
been shown that patient satisfaction is best assessed
using surveys targeted to a specific visit rather than
attempting to evaluate a general perception of an experi-
ence [6] and, moving forward, we aim to administer the
survey as patient visits occur and to target evaluation of
specific visits. Indeed, after reviewing responses for the
survey discussed here, we revised our instrument and
now distribute a two-page instrument with 27 Likert
scale questions and seven demographic questions. This
instrument is sent to patients immediately following a
consent, annual, or end of study visit. We intend to re-
port results from this instrument in a future publication.
A substantial limitation of this work is the lack of na-
tional benchmark data for the United States. We hope
that this preliminary effort to evaluate patient satisfac-
tion of clinical trial participants will act as a call to ac-
tion in the broader research community to begin
evaluation of the research patient experience and the im-
pact of research on the patient perception and utilization
of health care systems, ultimately leading to a nationally
standardized system of evaluation. This is of special
importance as, with any survey, the findings in this study
are based on a voluntary response sample and without
repeated and diverse sampling, the generalizability of the
results is diminished. Such repeated sampling is also cru-
cial if we are to identify areas of greatest importance to
the patients themselves, both to improve practices nation-
wide and to develop more concise instruments for receiv-
ing feedback from these important volunteers. Future
inquiry into research patient satisfaction would benefit
greatly from a mixed-methods approach, including ana-
lysis of structured interviews, to develop a more nuanced
description of the research patient experience. Ultimately,
research will also be required to determine the differences
in how patient satisfaction is measured and what is of
greatest import for patients engaging in clinical research
in countries with national health care compared to that of
research patients in the United States.
We hope, with this work, to be able to share our les-
sons learned with other members of the research com-
munity and proceed in collaboration with other research
organizations to develop and deploy a standardized sur-
vey, thereby beginning the important work of creating a
foundational understanding of clinical trial patient satis-
faction. Without such a system we are at risk of misun-
derstanding and effectively responding to the patient
voice. We now have an opportunity to explore another
realm of inquiry into clinical trial research and to validate
the generous contributions made by patients who put
themselves and their families at the forefront of medical
breakthroughs.
Conclusions
Satisfaction of patient volunteers in clinical trials is
grossly understudied. In an era of increasing focus on
the patient experience, this important subset of patients
receiving research-related health care services needs to
be queried to obtain a better understanding of how we
Table 5 Significant correlations
Likert scale items Correlation P value 95 % CI
I will seek future medical care at a MultiCare facility:
I would return to this health care provider for routine care 0.54 <0.001 0.38–0.67
Staff members treated me with respect 0.40 0.003 0.21–0.56
I will encourage family and friends to participate in studies 0.34 0.003 0.14–0.51
Staff responded quickly and fully to my concerns 0.38 0.005 0.19–0.55
I trusted the research staff members 0.38 0.006 0.18–0.54
Staff members were friendly 0.36 0.013 0.16–0.53
The environment was pleasant:
Scheduling my visits was easy 0.85 < 0.001 0.78–0.90
I trusted the research staff members 0.77 < 0.001 0.67–0.85
I was confident in the skills and knowledge of the staff 0.72 < 0.001 0.61–0.81
Staff responded quickly and fully to my concerns 0.70 < 0.001 0.58–0.79
Table 6 Motivations for volunteering
Motivation Number Percent
To contribute important information to
medical science
67 74.4
To potentially help other people with
similar conditions
67 74.4
I hoped that the research study would
improve my medical condition
61 67.8
To gain insights into my own health 42 46.7
To benefit from the additional medical
attention and testing that the study provided
42 46.7
Because of the financial incentives of the study 16 17.8
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can best serve these patients and how their experience in
research impacts their use of health care systems for
nonresearch-related care. Some similarities to nonresearch
patient satisfaction seem to be present, such as a strong
influence of interactions with care providers, but a na-
tional movement is needed among organizations conduct-
ing clinical trials in order to develop benchmarks and
create and understand the connections for these patients
between research-related and nonresearch-related care.
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Additional file 1: Survey instrument.pdf (copy of instrument used to
collect data reported in this manuscript). (PDF 335 kb)
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